Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 7 | |
Outperform | 16 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 22 analysts offering 12 month price targets for Legend Biotech Corp (ADR) have a median target of 84.50, with a high estimate of 95.00 and a low estimate of 60.00. The median estimate represents a 112.58% increase from the last price of 39.75.
High | 139.0% | 95.00 |
Med | 112.6% | 84.50 |
Low | 50.9% | 60.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 10, 2025.
Average growth rate | -146.64% |
Average growth rate | -38.80% |
More ▼
Revenue history & estimates in USD
Average growth rate | +21.35% |
Average growth rate | +64.22% |
More ▼